In 2009, Pathology Screening Pap Test (PathTezt®) R&D group in partnership with Biocytech Corp. The New Generation Liquid-Based Cytology (LBC) for cervical cancer screening test initial in Malaysia.
We are set up a research and development team moved to its custom built, state of the art manufacturing facility, incorporating the latest production technologies including complete clean room environment to the highest GMP standards.
We were approval a quality management system in accordance ISO 13485, ISO 9001, MDA, CE marked and FDA registration. For its Quality Management System (QMS) that is oriented towards the design, development, production, and installation of medical devices and a certificate of appreciation from State Council for Technology Upgradation for achieving excellence in production quality.
PathTezt® processor liquid-based cytology system is a new generation thin-layer pap preparation system, the processor is an automated computer-controlled device designed to prepare standardized thin-layer cytology preparations using a filtration process. Our filtration system is improvement limitations in terms of Technical Aspect problems, ease of operation and cost effectiveness (patchy cell lost and smears cell lost that show “halo”). Through its dedicated R&D teams from BIOCYTECH Corporation.
PathTezt™ (liquid-based cytology gives you more confidence in pap Results) is intended as a replacement for the conventional method of Pap smear test for use in screening for the presence of a typical cells, cervical cancer, or its precursor lesions (LSIL, HSIL).
